Comparison of the effect of 4-hydroxycoumarin and umbelliferone on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers

Pharmacological Reports

Volumn 60, Issue 4, 2008, Pages 555-560

  Wójtowicz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

4 hydroxycoumarin; Dipalmitoylphosphatidylcholine; Drug membrane interaction; DSC; Umbelliferone

Indexed keywords

4 HYDROXYCOUMARIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; UMBELLIFERONE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG STRUCTURE; ENTHALPY; FLUORESCENCE ANALYSIS; LIPID BILAYER; LIPID MEMBRANE; MICROCALORIMETRY; PHASE TRANSITION;

EID: 52049114174     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Biruss B, Dietl R, Valenta C: The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes. Chem Phys Lipids, 2007, 148, 84-90.
2. Biswas S, Bhattacharya SC, Bhownik BB, Moulik SP: Absorption and emission characteristics of 7-hydroxy-coumarin and 1-hydroxypyrene-3,6,8-trisulfate in water/oil microemulsion with reference to the determination of the interfacial and bulk pH of the water pool. J Coll Interface Sci, 2001, 244, 145-153.
3. Gagoś M, Menestrina G, Niewiadomy A, Gruszecki WI: Molecular organization of the antifungal and anticancer drug 2-(2,4-dihydroxyphenylo)-5,6-dichlorobenzothiazole in solution and in monolayers: an effect of pH. J Photochem Photobiol B, 2005, 80, 101-106.
4. Gagoś M, Niewiadomy A, Gruszecki WI: Molecular organization of the antifungal and anticancer drug 2-(2,4-dihydroxyphenylo)-5,6-dichlorobenzothiazole in solution and in lipid membranes studied by means of electronic absorption spectroscopy. J Photochem Photobiol B, 2004, 76, 33-40.
5. Hereć M, Islamow A, Kuklin A, Gagoś M, Gruszecki WI: Effect of antibiotic amphotericin B on structural and dynamic properties of lipid membranes formed with egg yolk phosphatidylcholine. Chem Phys Lipids, 2007, 147, 78-86.
6. Jain MK, Wu NM: Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayer. J Membr Biol, 1977, 34, 157-201.
7. Joshi UM, Codavanti PRS, Coudert B, Dwyer TM, Mehendale HM: Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther, 1988, 246, 150-157.
8. Jung JC, Lee JH, Oh S, Lee JG, Park OS: Synthesis and antitumor activity of 4-hydroxycoumarin derivatives. Bioorg Med Chem Lett, 2004, 14, 5527.
9. N. Spectrochim Acta Part A, 2001, 57, 41-47.
10. Lopez-Gonzalez JS, Prado-Garcia H, Aquillar-Cazares D, Molina-Gumeros JA, Morales-Fuentes J, Mandoki JJ: Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer, 2004, 43, 275-283.
11. Panicker L, Mishra KP: Nuclear magnetic resonance and thermal studies on the interaction between salicylic acid and model membranes. Biophys Chem, 2005, 120, 15-23.
12. Poxon SW, Hughes JA: Characterization of endotoxin and cationic liposome interaction. Pharm Dev Technol, 1999, 4, 135-143.
13. Ramesh B, Pugalendi KV: Antihyperlipidic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats. Yale J Biol Med, 2005, 78, 189-196.
14. Ramesh B, Pugalendi KV: Antioxidant role of umbelliferone in STZ-diabetic rats. Life Sci, 2006, 79, 306-310.
15. Ramesh B, Pugalendi KV: Effect of umbelliferone on tail tendon collagen and haemostatic function in streptozotocin-diabetic rats. Basic Clin Pharmacol Toxicol, 2007, 101, 73-77.
16. Ramesh B, Pugalendi KV: Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharmacol Rep, 2007, 59, 339-348.
17. Ramesh B, Viswanathan P, Pugalendi KV: Protective effect of umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats. Eur J Pharmacol, 2007, 566, 231-239.
18. Ratanasavanh D, Lamiable D, Biour M, Guedes Y, Gersberg M, Leutenegger E, Riche C: Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundam Clin Pharmacol, 1996, 10, 504-510.
19. 3 interacting with phospholipid bilayers of different thickness. Chem Phys Lipids, 1994, 74, 25-37.
20. Stefanova TH, Nikolova NJ, Toshkova RA, Neychev HO: Antitumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice. J Exp Theor Oncol, 2007, 6, 107-115.
21. Thati B, Noble A, Rowan R, Creaven, BS, Walsh M, Mc Cann M, Egan D, Kavanagh K: Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans. Toxicol In Vitro, 2007, 21, 801-808.
22. Wesołowska O, Hendrich AB, Motohashi N, Kawase M, Dobryszycki P, Ozyhar A, Michalak K: Presence of anionic phospholipids rules the membrane localization of phenothiazine type multidrug resistance modulator. Biophys Chem, 2004, 109, 399-412.
23. Wójtowicz K: The effect of 4-hydroxycoumarin and umbelliferone on DPPC bilayers. Ultrasound study. Eur Phys J Spec Top, 2008, 154, 285-288.